Shawn Kwatra, MD

Shawn Kwatra, MD

Johns Hopkins University

H-index: 37

North America-United States

About Shawn Kwatra, MD

Shawn Kwatra, MD, With an exceptional h-index of 37 and a recent h-index of 33 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of pruritus, prurigo nodularis, atopic dermatitis, skin of color, inflammatory skin diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Integrating skin color assessments into clinical practice and research: A review of current approaches

No increased risk of postoperative adverse events in total joint replacement patients with hidradenitis suppurativa

ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma

512-Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2

510-Dupilumab is efficacious in patients with prurigo nodularis regardless of stable use of topical corticosteroids and topical calcineurin inhibitors: pooled results from two …

526-Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

Bedside greater occipital nerve block with bupivacaine for the treatment of recalcitrant scalp pruritus

Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study

Shawn Kwatra, MD Information

University

Position

Assistant Professor of Dermatology

Citations(all)

4532

Citations(since 2020)

3878

Cited By

1586

hIndex(all)

37

hIndex(since 2020)

33

i10Index(all)

119

i10Index(since 2020)

108

Email

University Profile Page

Google Scholar

Shawn Kwatra, MD Skills & Research Interests

pruritus

prurigo nodularis

atopic dermatitis

skin of color

inflammatory skin diseases

Top articles of Shawn Kwatra, MD

Integrating skin color assessments into clinical practice and research: A review of current approaches

2024/2/9

No increased risk of postoperative adverse events in total joint replacement patients with hidradenitis suppurativa

Clinical and Experimental Dermatology

2024/2/3

ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma

Oncogene

2024/2/2

512-Dupilumab treatment improves satisfaction in patients with prurigo nodularis who did not achieve the multicomponent endpoint: analysis from LIBERTY-PN PRIME and PRIME2

British Journal of Dermatology

2024/2

510-Dupilumab is efficacious in patients with prurigo nodularis regardless of stable use of topical corticosteroids and topical calcineurin inhibitors: pooled results from two …

British Journal of Dermatology

2024/2

526-Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study

British Journal of Dermatology

2024/2

Bedside greater occipital nerve block with bupivacaine for the treatment of recalcitrant scalp pruritus

JAAD Case Reports

2024/2/1

Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort study

Journal of the American Academy of Dermatology

2024/2/1

Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides

Scientific reports

2024/1/23

Dysregulation of the Skin–Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis

Genes

2024/1/23

Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort

British Journal of Dermatology

2024/1/23

Single-cell RNA sequencing reveals dysregulated POSTN+ WNT5A+ fibroblast subclusters in prurigo nodularis

Journal of Investigative Dermatology

2024/1/20

De novo autoimmune connective tissue disease and mortality in patients treated with anti-PD-1 and anti-PD-L1 therapy: a population-level cohort study

The British journal of dermatology

2024/4/28

Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo

JAMA dermatology

2024/1/17

Dupilumab therapy modulates circulating inflammatory mediators in patients with prurigo nodularis

JID Innovations

2024/4/12

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for Immunotherapy of Cancer

2024

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)

JAAD International

2024/4/10

United States expert panel consensus on uniform nomenclature and diagnosis for neuropathic pruritus

Itch

2024/1/1

Rapid improvements in itch with tapinarof cream 1% once daily in two phase 3 trials in adults with mild to severe plaque psoriasis

Dermatology and Therapy

2024/1

Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood Type 2 inflammation.

JAAD International

2024/4/7

See List of Professors in Shawn Kwatra, MD University(Johns Hopkins University)